SCOPUS 정보 검색 플랫폼

Volumn 15, Issue 4, 1997, Pages 444-445

A new phenytoin prodrug, Cerebyx® [7]

Author keywords

[No Author keywords available]

Indexed keywords

FOSPHENYTOIN SODIUM; PHENYTOIN;

ANTICONVULSANT ACTIVITY; DRUG EFFICACY; DRUG ELIMINATION; DRUG INDUSTRY; HUMAN; LETTER; PATIENT MONITORING; PRIORITY JOURNAL; SEIZURE;

EID: 0030739215 PISSN: 07356757 EISSN: None Source Type: Journal
DOI: 10.1016/S0735-6757(97)90151-0 Document Type: Letter

Times cited : (1)

References (5)

1
- 85114537002
- Cerebyx®—Ready reference guide to prescribing information
- Cerebyx®—Ready reference guide to prescribing information 1996 Parke-Davis, Warner-Lambert Co Morris Plains, NJ
- (1996)

2
- 4243713983
- Pharmacologic considerations of fosphenytoin therapy
- J Cloyd Pharmacologic considerations of fosphenytoin therapy Pharmacol Ther 70 suppl May 1996 13S 20S
- (1996) Pharmacol Ther , vol.70 , Issue.suppl May , pp. 13S-20S
- Cloyd, J¹

3
- 0025238997
- Pharmacokinetics and safety of a phenytoin prodrug given IV or IM in patients
- IE Leppick BA Boucher BS Murthy Pharmacokinetics and safety of a phenytoin prodrug given IV or IM in patients Neurology 40 1990 456 460
- (1990) Neurology , vol.40 , pp. 456-460
- Leppick, IE¹ Boucher, BA² Murthy, BS³

4
- 85054266386
- Fosphenytoin sodium (Cerebyx®, Parke-Davis): Where will it fit?
- AE Shirer Fosphenytoin sodium (Cerebyx®, Parke-Davis): Where will it fit? Question-of-the-Month 1 1996 2 4
- (1996) Question-of-the-Month , vol.1 , pp. 2-4
- Shirer, AE¹

5
- 0020625027
- Brain regional pharmacokinetics of 11C-labeled diphenylhydaintoin: positron emission tomography in humans
- JC Baron D Roeda C Munari Brain regional pharmacokinetics of 11C-labeled diphenylhydaintoin: positron emission tomography in humans Neurology 33 1983 580 585
- (1983) Neurology , vol.33 , pp. 580-585
- Baron, JC¹ Roeda, D² Munari, C³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.